##common.pageHeaderLogo.altText##

Original article

Vol. 155 No. 8 (2025)

The impact of the COVID-19 pandemic on cancer incidence, stage distribution and survival in Switzerland: a register-based cohort study

Cite this as:
Swiss Med Wkly. 2025;155:4354
Published
05.08.2025

Summary

BACKGROUND: The COVID-19 pandemic disrupted healthcare systems worldwide. This raised concerns about delays in cancer diagnosis and treatment, with potentially worse patient outcomes. The aim of this nationwide, population-based cohort study was to investigate the impact of the COVID-19 pandemic on cancer incidence, stage distribution and one-year survival in Switzerland.

METHODS: We used national cancer registry data for the period 2017–2021 from the National Agency for Cancer Registration in Switzerland, covering all except three cantons. We estimated national cancer incidence counts and calculated age-standardised incidence rates for all cancers and separately for female breast cancer, colorectal cancer, lung cancer, melanoma and prostate cancer. We calculated proportional stage distributions for cancer types and estimated observed and relative one-year survival for all cancers and cancer types based on Swiss population life tables. Results were analysed descriptively.

RESULTS: We included 218,736 cancer cases diagnosed between 2017 and 2021. Annual incidence counts of all cancer cases increased in 2020 (2.1%) and 2021 (7.3%) compared to the mean of 2017–2019. When evaluating monthly incidence counts, we observed a substantial decrease during the COVID-19 lockdown period, which was largest in April 2020 (−19.9% for all cancers). This decrease was most pronounced for female breast cancer (−39.9%), followed by prostate cancer (−29.0%), colorectal cancer (−28.7%) and melanoma (−26.9%). An increase in incidence counts for all cancers was observed in March 2021 (18.8%). We observed no clear shift in stage distributions across 2017–2021. The observed and relative one-year survival for all cancers and individual cancer types was similar in 2020 and slightly higher in 2021 compared to 2017–2019.

CONCLUSIONS: This nationwide study suggests that the pandemic had no major effect on short-term cancer patient outcomes. These findings are of importance for policymakers and the public health system regarding future pandemics.

References

  1. Moynihan R, Sanders S, Michaleff ZA, Scott AM, Clark J, To EJ, et al. Impact of COVID-19 pandemic on utilisation of healthcare services: a systematic review. BMJ Open. 2021 Mar;11(3):e045343. doi: https://doi.org/10.1136/bmjopen-2020-045343
  2. Greene GJ, Thomson CS, Donnelly D, Chung D, Bhatti L, Gavin AT, et al. Whole-population trends in pathology-confirmed cancer incidence in Northern Ireland, Scotland and Wales during the SARS-CoV-2 pandemic: A retrospective observational study. Cancer Epidemiol. 2023 Jun;84:102367. doi: https://doi.org/10.1016/j.canep.2023.102367
  3. Johansson AL, Larønningen S, Skovlund CW, Kristiansen MF, Mørch LS, Friis S, et al. The impact of the COVID-19 pandemic on cancer diagnosis based on pathology notifications: A comparison across the Nordic countries during 2020. Int J Cancer. 2022 Aug;151(3):381–95. doi: https://doi.org/10.1002/ijc.34029
  4. Mitchell H, Mclean J, Gavin AT, Visser O, Millar E, Luff T, et al. Impact of COVID-19 control on lung, breast, and colorectal pathological cancer diagnoses. A comparison between the Netherlands, Aotearoa New Zealand, and Northern Ireland. BMC Cancer. 2023 Jul;23(1):700. doi: https://doi.org/10.1186/s12885-023-11216-3
  5. Negoita S, Chen HS, Sanchez PV, Sherman RL, Henley SJ, Siegel RL, et al. Annual Report to the Nation on the Status of Cancer, part 2: early assessment of the COVID-19 pandemic’s impact on cancer diagnosis. Cancer. 2024 Jan;130(1):117–27. doi: https://doi.org/10.1002/cncr.35026
  6. Peacock HM, Tambuyzer T, Verdoodt F, Calay F, Poirel HA, De Schutter H, et al. Decline and incomplete recovery in cancer diagnoses during the COVID-19 pandemic in Belgium: a year-long, population-level analysis. ESMO Open. 2021 Aug;6(4):100197. doi: https://doi.org/10.1016/j.esmoop.2021.100197
  7. Trojanowski M, Radomyski P, Kycler W, Michalek IM. Decrease in the number of new cancer diagnoses during the first year of the COVID-19 pandemic - cohort study of 3.5 million individuals in western Poland. Front Oncol. 2023 Dec;13:1230289. doi: https://doi.org/10.3389/fonc.2023.1230289
  8. Zagar T, Tomsic S, Zadnik V, Bric N, Birk M, Vurzer B, et al. Impact of the COVID-19 epidemic on cancer burden and cancer care in Slovenia: a follow-up study. Radiol Oncol. 2022 Dec;56(4):488–500. doi: https://doi.org/10.2478/raon-2022-0050
  9. Greene G, Griffiths R, Han J, Akbari A, Jones M, Lyons J, et al. Impact of the SARS-CoV-2 pandemic on female breast, colorectal and non-small cell lung cancer incidence, stage and healthcare pathway to diagnosis during 2020 in Wales, UK, using a national cancer clinical record system. Br J Cancer. 2022 Aug;127(3):558–68. doi: https://doi.org/10.1038/s41416-022-01830-6
  10. Peacock HM, De Gendt C, Silversmit G, Nuyts S, Casselman J, Machiels JP, et al. Stage shift and relative survival for head and neck cancer during the 2020 COVID-19 pandemic: a population-based study of temporal trends. Front Oncol. 2023 Sep;13:1253968. doi: https://doi.org/10.3389/fonc.2023.1253968
  11. Reinwald F, Justenhoven C. Impact of the COVID-19 pandemic on number and stages of tumors - data of a German cancer registry. Acta Oncol. 2023 Mar;62(3):315–7. doi: https://doi.org/10.1080/0284186X.2023.2187259
  12. Peacock HM, Van Meensel M, Van Gool B, Silversmit G, Dekoninck K, Brierley JD, et al. Cancer incidence, stage shift and survival during the 2020 COVID-19 pandemic: A population-based study in Belgium. Int J Cancer. 2024 Oct;155(7):1212–24. doi: https://doi.org/10.1002/ijc.35001
  13. Angelini M, Teglia F, Astolfi L, Casolari G, Boffetta P. Decrease of cancer diagnosis during COVID-19 pandemic: a systematic review and meta-analysis. Eur J Epidemiol. 2023 Jan;38(1):31–8. doi: https://doi.org/10.1007/s10654-022-00946-6
  14. Bundesamt für Statistik. Auswirkungen der Covid-19-Pandemie auf die Gesundheitsversorgung im Jahr 2020. Neuchâtel; 2021. Available from: https://www.bfs.admin.ch/news/de/2021-0247
  15. Wirth B, Stucki M, Joerg R, Thommen C, Höglinger M. Impact of the Covid-19 pandemic on inpatient health care in Switzerland 2020-2021-A descriptive retrospective study using admission data of all Swiss hospitals. PLoS One. 2024 Jul;19(7):e0306791. doi: https://doi.org/10.1371/journal.pone.0306791
  16. Bennett D, Murray I, Mitchell H, Gavin A, Donnelly D. Impact of COVID-19 on cancer incidence, presentation, diagnosis, treatment and survival in Northern Ireland. Int J Cancer. 2024 May;154(10):1731–44. doi: https://doi.org/10.1002/ijc.34847
  17. Puricelli Perin DM, Elfström KM, Bulliard JL, Burón A, Campbell C, Flugelman AA, et al.; International Cancer Screening Network. Early assessment of the first wave of the COVID-19 pandemic on cancer screening services: The International Cancer Screening Network COVID-19 survey. Prev Med. 2021 Oct;151:106642. doi: https://doi.org/10.1016/j.ypmed.2021.106642
  18. Kostner L, Cerminara SE, Pamplona GS, Maul JT, Dummer R, Ramelyte E, et al. Effects of COVID-19 Lockdown on Melanoma Diagnosis in Switzerland: Increased Tumor Thickness in Elderly Females and Shift towards Stage IV Melanoma during Lockdown. Cancers (Basel). 2022 May;14(10):2360. 10.3390/cancers14102360
  19. Suter F, Wanner M, Menges D, Wicki A, Korol D, Rohrmann S. Impact of the COVID-19 Pandemic and Lockdown on Cancer Diagnoses Using Swiss Cantonal Cancer Registry Data. Cancers (Basel). 2024 Oct;16(19):3381. doi: https://doi.org/10.3390/cancers16193381
  20. Federal Office of Public Health (FOPH). Gesetzgebung Krebsregistrierung. 2025. Available from: https://www.bag.admin.ch/de/gesetzgebung-krebsregistrierung-datenbearbeitung-und-datennutzung
  21. World Health Organization. ICD-10 Version: 2019 – International Statistical Classification of Diseases and Related Health Problems 10th Revision. Available from: https://icd.who.int/browse10/2019/en
  22. R Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing; 2024. Internet: https://www.R-project.org/
  23. Abawi K, Feller A, Lorez M, Michalopoulou E, Roy E, Spycher B, et al. Statistical Methods for Cancer Reporting in Switzerland. Zürich, Bern, Neuchâtel. National Agency for Cancer Registration (NACR), Childhood Cancer Registry (ChCR), Federal Statistical Office (FSO). 2022. Available from: https://www.kinderkrebsregister.ch/wp-content/uploads/sites/2/2022/06/Methodenbericht_final_20220617.pdf
  24. Fay MP, Feuer EJ. Confidence intervals for directly standardized rates: a method based on the gamma distribution. Stat Med. 1997 Apr;16(7):791–801. doi: https://doi.org/10.1002/(SICI)1097-0258(19970415)16:7<791::AID-SIM500>3.0.CO;2-#
  25. Union for International Cancer Control (UICC). TNM Classification of Malignant Tumours, 8th Edition: Wiley-Blackwell; 2017. Internet: https://www.uicc.org/what-we-do/sharing-knowledge/tnm
  26. Corazziari I, Quinn M, Capocaccia R. Standard cancer patient population for age standardising survival ratios. Eur J Cancer. 2004 Oct;40(15):2307–16. doi: https://doi.org/10.1016/j.ejca.2004.07.002
  27. Ederer F, Hernan H. Instructions to IBM 650 programmers in processing survival computations. No. 10. Methodological note. End Results Evaluation Section. Bethesda (MD): National Cancer Institute; 1959.
  28. Miettinen J, Rantanen M. popEpi: Functions for Epidemiological Analysis using Population Data. R package version 0.4.12. 2024. Internet: https://CRAN.R-project.org/package=popEpi
  29. Voigtländer S, Hakimhashemi A, Grundmann N, Radespiel-Tröger M, Inwald EC, Ortmann O, et al. Impact of the COVID-19 pandemic on reported cancer diagnoses in Bavaria, Germany. J Cancer Res Clin Oncol. 2023 Aug;149(10):7493–503. doi: https://doi.org/10.1007/s00432-023-04707-0
  30. Bundesamt für Statistik. Hospitalisierungen mit Covid-19-Diagnose 2020 und 2021. Neuchâtel; 2022. Available from: https://www.bfs.admin.ch/bfs/de/home/aktuell/neue-veroeffentlichungen.assetdetail.23771995.html
  31. Allemani C, Matsuda T, Di Carlo V, Harewood R, Matz M, Nikšić M, et al.; CONCORD Working Group. Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet. 2018 Mar;391(10125):1023–75. doi: https://doi.org/10.1016/S0140-6736(17)33326-3